These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31485194)

  • 1. Implication of IL-17 in Bone Loss and Structural Damage in Inflammatory Rheumatic Diseases.
    Le Goff B; Bouvard B; Lequerre T; Lespessailles E; Marotte H; Pers YM; Cortet B
    Mediators Inflamm; 2019; 2019():8659302. PubMed ID: 31485194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis.
    Blauvelt A; Chiricozzi A
    Clin Rev Allergy Immunol; 2018 Dec; 55(3):379-390. PubMed ID: 30109481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis.
    Shaw AT; Maeda Y; Gravallese EM
    Arthritis Res Ther; 2016 May; 18(1):104. PubMed ID: 27165410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
    Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
    Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental Spondyloarthritis.
    van Tok MN; van Duivenvoorde LM; Kramer I; Ingold P; Pfister S; Roth L; Blijdorp IC; van de Sande MGH; Taurog JD; Kolbinger F; Baeten DL
    Arthritis Rheumatol; 2019 Apr; 71(4):612-625. PubMed ID: 30390386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-17A Interweaves the Skeletal and Immune Systems.
    Tang M; Lu L; Yu X
    Front Immunol; 2020; 11():625034. PubMed ID: 33613566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Patents Targeting Interleukin-17A; Implications in Cancer and Inflammation.
    Santibanez JF; Bjelica S
    Recent Pat Anticancer Drug Discov; 2018; 13(2):133-144. PubMed ID: 29468982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti IL-17A therapy inhibits bone loss in TNF-α-mediated murine arthritis by modulation of the T-cell balance.
    Zwerina K; Koenders M; Hueber A; Marijnissen RJ; Baum W; Heiland GR; Zaiss M; McLnnes I; Joosten L; van den Berg W; Zwerina J; Schett G
    Eur J Immunol; 2012 Feb; 42(2):413-23. PubMed ID: 22101928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bispecific antibody aimed at the vicious circle of IL-1β and IL-17A, is beneficial for the collagen-induced rheumatoid arthritis of mice through NF-κB signaling pathway.
    Wu Q; Wang Y; Wang Q; Yu D; Wang Y; Song L; Liu Z; Ye X; Xu P; Cao H; Li D; Ren G
    Immunol Lett; 2016 Nov; 179():68-79. PubMed ID: 27616043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts.
    Uluçkan Ö; Jimenez M; Karbach S; Jeschke A; Graña O; Keller J; Busse B; Croxford AL; Finzel S; Koenders M; van den Berg W; Schinke T; Amling M; Waisman A; Schett G; Wagner EF
    Sci Transl Med; 2016 Mar; 8(330):330ra37. PubMed ID: 27089206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriatic inflammation causes hepatic inflammation with concomitant dysregulation in hepatic metabolism via IL-17A/IL-17 receptor signaling in a murine model.
    Al-Harbi NO; Nadeem A; Al-Harbi MM; Zoheir KMA; Ansari MA; El-Sherbeeny AM; Alanazi KM; Alotaibi MR; Ahmad SF
    Immunobiology; 2017 Feb; 222(2):128-136. PubMed ID: 27773660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond.
    Brembilla NC; Senra L; Boehncke WH
    Front Immunol; 2018; 9():1682. PubMed ID: 30127781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritis.
    Toussirot E
    Expert Opin Biol Ther; 2018 Jan; 18(1):101-107. PubMed ID: 29187009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of IL-1β in the bone loss during rheumatic diseases.
    Ruscitti P; Cipriani P; Carubbi F; Liakouli V; Zazzeroni F; Di Benedetto P; Berardicurti O; Alesse E; Giacomelli R
    Mediators Inflamm; 2015; 2015():782382. PubMed ID: 25954061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms.
    Tam HKJ; Robinson PC; Nash P
    Curr Rheumatol Rep; 2022 Oct; 24(10):310-320. PubMed ID: 35861937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of IL-33 in the epidermis: The mechanism of induction by IL-17.
    Meephansan J; Komine M; Tsuda H; Karakawa M; Tominaga S; Ohtsuki M
    J Dermatol Sci; 2013 Aug; 71(2):107-14. PubMed ID: 23764374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis: rationale for targeting interleukin-17.
    Girolomoni G; Mrowietz U; Paul C
    Br J Dermatol; 2012 Oct; 167(4):717-24. PubMed ID: 22716185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis.
    Chao CC; Chen SJ; Adamopoulos IE; Davis N; Hong K; Vu A; Kwan S; Fayadat-Dilman L; Asio A; Bowman EP
    Autoimmunity; 2011 May; 44(3):243-52. PubMed ID: 20925596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation.
    Cheung PF; Wong CK; Lam CW
    J Immunol; 2008 Apr; 180(8):5625-35. PubMed ID: 18390747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.